Quantum Cyber N.V. Company Profile
NASDAQ: QUCYHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Quantum Cyber N.V. at a glance
Quantum Cyber N.V. (NASDAQ: QUCY) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in Mainz, Germany. Quantum Cyber N.V. is led by Mr. David Elliot Lazar and employs about 10 people. The company's shares have traded publicly since 2021.
At a market capitalization of $113.5 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001874252, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does Quantum Cyber N.V. do?
Quantum Cyber N.V. operates as a technology company focused on cybersecurity and quantum computing solutions. The company pursues acquisitions and partnerships in areas including post-quantum cryptography, zero-trust architecture, and national security technologies. It also develops platforms that integrate artificial intelligence (AI) and quantum computing technologies for autonomous control systems used in unmanned aerial, ground, and underwater vehicles, including drones, self-driving vehicles, and robotic fleets. Quantum Cyber N.V. was formerly known as Mainz Biomed N.V. and changed its name to Quantum Cyber N.V. in April 2026. The company is headquartered in Mainz, Germany.
Business description based on the company's public filings.
Company information
- Legal name
- Quantum Cyber N.V.
- Ticker
- NASDAQ: QUCY
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- CEO
- Mr. David Elliot Lazar
- Employees
- 10
- Headquarters
- Robert Koch Strasse 50, Mainz, Germany
- Phone
- 49 6131 554 2860
- Website
- quantum-cyber.ai
- IPO year
- 2021
- Market cap
- $113.49M
- SEC CIK
- 0001874252
Companies similar to Quantum Cyber N.V.
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| UNCYUnicycive Therapeutics Inc. | 4.11 | +0.98% | $112.59M | vs QUCY |
| RANIRani Therapeutics Holdings Inc. Class A | 0.799 | +0.88% | $112.28M | vs QUCY |
| PMVPPMV Pharmaceuticals Inc. | 1.52 | +2.01% | $114.78M | vs QUCY |
| IMUXImmunic Inc. | 8.19 | +8.33% | $111.75M | vs QUCY |
| GNLXGenelux Corporation | 2.56 | +2.40% | $115.83M | vs QUCY |
| COYACoya Therapeutics Inc. | 4.95 | -0.80% | $116.12M | vs QUCY |
| FHTXFoghorn Therapeutics Inc. | 2.00 | +0.50% | $118.77M | vs QUCY |
| INOInovio Pharmaceuticals Inc. | 1.15 | +5.50% | $118.91M | vs QUCY |